The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
Open accessAbstract
BACKGROUND: The incidence of venous thromboembolism (VTE) is increased in cancer, but little information is available about risk factors in cancer patients on chemotherapy. METHODS: We analyzed data from a prospective, multicenter observational study to determine the frequency and risk factors for VTE in ambulatory cancer patients initiating a new chemotherapy regimen. The association of VTE with clinical variables was characterized using univariate and multivariate analysis. RESULTS: Among 3003 patients treated with at least one cycle of chemotherapy, VTE occurred in 58 (1.93%) over a median follow‐up of 2.4 months (0.8%/mo). The incidence varied significantly by site of cancer (P = 0.01) with highest rates in upper gastrointestinal (2.3%/mo) and lung cancer (1.2%/mo), and lymphoma (1.1%/mo). An elevated prechemotherapy platelet count was significantly associated with an increased rate of VTE (P for trend = 0.005). The incidence of VTE was 3.98% (1.66%/mo) for patients with a prechemotherapy platelet count ≥ 350,000, compared with 1.25% (0.52%/mo) for patients with platelet counts of < 200,000 (P for trend=0.0003). In multivariate analysis, a prechemotherapy platelet count of ≥ 350,000/mm 3 (adjusted OR 2.81, 95% CI 1.63–4.93, P = 0.0002), site of cancer, hemoglobin < 10g/dL or use of erythropoietin, and use of white cell growth factors in high‐risk sites of cancer were significantly associated with VTE. CONCLUSIONS: Symptomatic VTE is a frequent complication of chemotherapy. The prechemotherapy platelet count is a unique risk factor and can help identify high‐risk patients for future trials of thromboprophylaxis. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Levitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.14 · Cited by 749
Venous Thromboembolism and Cancer: Risks and Outcomes
Lee, A. Y. Y., & Levine, M. N. (2003) · Circulation · doi:10.1161/01.cir.0000078466.72504.ac · Cited by 721
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., & Bugge, T. H. (2000) · Blood · doi:10.1182/blood.v96.10.3302 · Cited by 605
Causes of death in cancer patients
Inagaki, J., Rodriguez, V., & Bodey, G. P. (1974) · Cancer · doi:10.1002/1097-0142(197402)33:2<568::aid-cncr2820330236>3.0.co;2-2 · Cited by 601
The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate
Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Kehoe, S. T. (2002) · Neoplasia · doi:10.1038/sj.neo.7900263 · Cited by 576
Infection and inflammation and the coagulation system
Levi, M. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00857-x · Cited by 517
Levine, M., Hirsh, J., Arnold, A., Gent, M., Levine, M., Arnold, A., Bramwell, V., Pritchard, K. I., Stewart, D., Warr, D., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 510
Alikhan, R., Cohen, A. T., Combe, S., Samama, M. M., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Olsson, C.-G., & Turpie, A. G. G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.963 · Cited by 481
Thromboembolism in Hospitalized Neutropenic Cancer Patients
Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., & Lyman, G. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8877 · Cited by 475
Self-citationThe Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
Levine, M. N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M. D., Hryniuk, W., & De Pauw, S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180703 · Cited by 412
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
Wan, J., Nguyen, N., & Sallah, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613051 · Cited by 411
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
Saphner, T., Tormey, D. C., & Gray, R. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.2.286 · Cited by 396
Tissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Tracy, R. P., Aleksic, N., & Folsom, A. R. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01345-1 · Cited by 376
Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318882 · Cited by 317
Poor prognosis associated with thrombocytosis in patients with gastric cancer
Ikeda, M., Furukawa, H., Imamura, H., Shimizu, J., Ishida, H., Masutani, S., Tatsuta, M., & Satomi, T. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02573067 · Cited by 292
Causes of death in cancer patients.
Ambrus, J. L., Ambrus, C. M., Mink, I. B., & Pickren, J. W. (1975) · PubMed · Cited by 282
Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
Elting, L. S., Escalante, C. P., Cooksley, C., Avritscher, E. B. C., Kurtin, D., Hamblin, L., Khosla, S. G., & Rivera, E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1653 · Cited by 269
Pancreatic cancer and thromboembolic disease
Khorana, A. A., & Fine, R. L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01606-7 · Cited by 269
Self-citationPritchard, K. I., Paterson, A. H., Paul, N. A., Zee, B., Fine, S., & Pater, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2731 · Cited by 269
Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey
Kakkar, A. K., Levine, M., Pinedo, H. M., Wolff, R., & Wong, J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-381 · Cited by 207
Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score
Zakai, N. A., Wright, J., & Cushman, M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00991.x · Cited by 202
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Undas, A., Sydor, W., Brummel, K. E., Musiał, J., Mann, K. G., & Szczeklik, A. (2003) · Circulation · doi:10.1161/01.cir.0000047062.03282.a3 · Cited by 189
Malignancy, thrombosis and Trousseau: the case for an eponym
Khorana, A. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00501.x · Cited by 166
Self-citationFalanga, A., Marchetti, M., Evangelista, V., Manarini, S., Oldani, E., Giovanelli, S., Galbusera, M., Cerletti, C., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.8.2506 · Cited by 158
Cavo, M., Zamagni, E., Cellini, C., Tosi, P., Cangini, D., Cini, M., Valdré, L., Palareti, G., Masini, L., Tura, S., et al. (2002) · Blood · doi:10.1182/blood-2002-06-1674 · Cited by 152
Wun, T., Law, L. Y., Harvey, D. J., Sieracki, B., Scudder, S., & Ryu, J. K. (2003) · Cancer · doi:10.1002/cncr.11700 · Cited by 139
Kuenen, B. C., Levi, M. M., Meijers, J. C. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.046 · Cited by 121
Pathogenesis of Thrombosis in Patients with Malignancy
Falanga, A., & Donati, M. B. (2001) · International Journal of Hematology · doi:10.1007/bf02981929 · Cited by 111
Lectures ON CLINICAL MEDICINE,
Walshe, W. H. (1849) · The Lancet · doi:10.1016/s0140-6736(02)65117-7 · Cited by 97
Thrombocytosis as a Useful Prognostic Indicator in Patients with Lung Cancer
Aoe, K., Hiraki, A., Ueoka, H., Kiura, K., Tabata, M., Tanaka, M., & Tanimoto, M. (2004) · Respiration · doi:10.1159/000076679 · Cited by 96
Potentiation of Endothelial Cell Proliferation by Fibrin(ogen)-bound Fibroblast Growth Factor-2
Sahni, A., Sporn, L. A., & Francis, C. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14936 · Cited by 83
Self-citationThrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis
Barbul, T., Finazzi, G., Grassi, A., & Marchioli, R. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650276 · Cited by 70
Eastman, M. E., Khorsand, M., Maki, D. G., Williams, E. C., Kim, K., Sondel, P. M., Schiller, J. H., & Albertini, M. R. (2001) · Cancer · Cited by 44
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Self-citationThromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Self-citation
Metadata
- Authors
- Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-11-13
- Volume
- 104
- Issue
- 12
- Pages
- 2822-2829
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1573083214
- Cited by
- 565
- References
- 42
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.